Zhejiang Medicine Gestione

Gestione criteri di controllo 3/4

Zhejiang Medicine Il CEO è Chun Lei Lu, nominato in Jun2018, ha un mandato di 6.42 anni. possiede direttamente 0.035% delle azioni della società, per un valore di CN¥ 5.39M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.4 anni e 3.4 anni.

Informazioni chiave

Chun Lei Lu

Amministratore delegato

CN¥2.8m

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	6.4yrs
Proprietà del CEO	0.04%
Durata media del management	3.4yrs
Durata media del Consiglio di amministrazione	3.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Chun Lei Lu (57 yo)

6.4yrs

Mandato

CN¥2,844,200

Compensazione

Mr. Chun Lei Lu is President and Director of Zhejiang Medicine Co., Ltd. since June 15, 2018. He serves as Vice Chairman of Zhejiang Medicine Co., Ltd.since June 16, 2021. Mr. Lu was Executive Vice Presid...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Chun Lei Lu	President & Vice Chairman	6.4yrs	CN¥2.84m	0.035% CN¥ 5.4m
Hongwei Wang	Executive Vice President	6.4yrs	CN¥2.61m	0.019% CN¥ 3.0m
Huan Ming Yu	Vice President	9.4yrs	CN¥2.05m	0.042% CN¥ 6.3m
Jianhong Ping	Vice President	3.4yrs	CN¥1.90m	0.0052% CN¥ 793.1k
Yongbin An	Senior Manager	3.4yrs	CN¥2.24m	Nessun dato
Liping Liang	Senior Manager	3.4yrs	CN¥1.97m	0.0078% CN¥ 1.2m
Xiaoping Wang	Senior Manager	3.4yrs	CN¥2.10m	0.0052% CN¥ 793.1k
Nan Xing Li	Vice Chairman & Vice President	6.4yrs	CN¥2.86m	0.12% CN¥ 17.7m
Qirong Li	CFO & Financial Director	3.4yrs	CN¥1.22m	0.0052% CN¥ 793.1k
Guangshan Guo	Accounting Supervisor	no data	Nessun dato	Nessun dato
Minzhi Shao	Board Secretary	1.2yrs	Nessun dato	Nessun dato
Jin Lin Zhu	Vice President	9.4yrs	CN¥1.82m	0.036% CN¥ 5.6m

3.4yrs

Durata media

50yo

Età media

Gestione esperta: Il team dirigenziale di 600216 è considerato esperto (durata media dell'incarico 3.4 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Chun Lei Lu	President & Vice Chairman	12.4yrs	CN¥2.84m	0.035% CN¥ 5.4m
Nan Xing Li	Vice Chairman & Vice President	6.4yrs	CN¥2.86m	0.12% CN¥ 17.7m
Chun Bo Li	Chairman of the Board	21.4yrs	CN¥3.46m	0.0097% CN¥ 1.5m
Naiwei Chen	Independent Director	6.4yrs	CN¥120.00k	Nessun dato
Yizheng Qiu	Independent Director	3.4yrs	CN¥120.00k	Nessun dato
Zhenhua Chu	Director	3.4yrs	CN¥1.86m	0.0078% CN¥ 1.2m
Yuqing Yu	Director	3.4yrs	CN¥1.85m	0.0052% CN¥ 793.1k
Qing Xia	Independent Director	3.4yrs	CN¥120.00k	Nessun dato
Xiaoming Wu	Independent Director	2.9yrs	CN¥120.00k	Nessun dato
Zhong Liu	Vice Chairman	1.4yrs	Nessun dato	Nessun dato
Yiyuan Wu	Chief Supervisor	1.4yrs	Nessun dato	Nessun dato
Hongyu Cang	Director	1.4yrs	Nessun dato	Nessun dato

3.4yrs

Durata media

48.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 600216 sono considerati esperti (durata media dell'incarico 3.4 anni).

Zhejiang Medicine Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Zhejiang Medicine Co., Ltd., Annual General Meeting, Jun 18, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.55 (vs CN¥0.029 in 3Q 2023)

Investor sentiment improves as stock rises 20%

Zhejiang Medicine Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released: EPS: CN¥0.23 (vs CN¥0.16 in 2Q 2023)

New minor risk - Share price stability

Investor sentiment improves as stock rises 19%

Dividend reduced to CN¥0.15

Zhejiang Medicine Co., Ltd. to Report First Half, 2024 Results on Aug 23, 2024

Zhejiang Medicine Co., Ltd., Annual General Meeting, Jun 18, 2024

First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.12 in 1Q 2023)

Zhejiang Medicine Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Investor sentiment improves as stock rises 18%

Zhejiang Medicine Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.029 (vs CN¥0.10 in 3Q 2022)

Zhejiang Medicine Co., Ltd. to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.14 in 2Q 2022)

Zhejiang Medicine Co., Ltd. to Report First Half, 2023 Results on Aug 24, 2023

First quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.27 in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.25 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.25 in 2Q 2021)

Less than half of directors are independent

Third quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.30 in 2Q 2020)

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS CN¥0.75 (vs CN¥0.36 in FY 2019)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥15.25

New 90-day low: CN¥12.75

New 90-day low: CN¥13.19

Third quarter earnings released

Third quarter earnings released

New 90-day low: CN¥14.55

Zhejiang Medicine Co., Ltd. to Report Q3, 2020 Results on Oct 23, 2020

New 90-day low: CN¥15.44

New 90-day low - CN¥16.73

First half earnings released

Earnings released

Zhejiang Medicine Co., Ltd. to Report First Half, 2020 Results on Aug 26, 2020

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media